Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,418 GBX | -0.08% | -0.02% | +16.74% |
01:20pm | ASTRAZENECA : Goldman Sachs maintains a Buy rating | ZD |
10:34am | AstraZeneca disappointed by breast cancer drug trial results | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.74% | 244B | |
+52.09% | 797B | |
+40.58% | 628B | |
-6.85% | 351B | |
+17.00% | 323B | |
+10.14% | 300B | |
+0.90% | 223B | |
+5.12% | 163B | |
-5.82% | 153B | |
-1.40% | 118B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Berenberg Raises AstraZeneca PT, Maintains Buy Rating